BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27058616)

  • 1. Translation, Cross-Cultural Adaptation, and Validation of the Lee Chronic Graft-versus-Host Disease Symptom Scale in a Brazilian Population.
    Vasconcellos de Souza C; Vigorito AC; Miranda ECM; Garcia C; Rensi Colturato VA; Mauad MA; Rodrigues Moreira MC; da Silva Bouzas LF; Lermontov S; Hamerschlak N; Rodrigues M; Carlos de Almeida Barros J; Chiattone R; Lee SJ; Flowers MED
    Biol Blood Marrow Transplant; 2016 Jul; 22(7):1313-1318. PubMed ID: 27058616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a scale to measure symptoms of chronic graft-versus-host disease.
    Lee Sk; Cook EF; Soiffer R; Antin JH
    Biol Blood Marrow Transplant; 2002; 8(8):444-52. PubMed ID: 12234170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Content Validity of the Lee Chronic Graft-versus-Host Disease Symptom Scale as Assessed by Cognitive Interviews.
    Merkel EC; Mitchell SA; Lee SJ
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):752-758. PubMed ID: 26751003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of the human activity profile questionnaire in patients after allogeneic hematopoietic stem cell transplantation.
    Herzberg PY; Heussner P; Mumm FH; Horak M; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix H; Freund M; Lee SJ; Holler E; Wolff D
    Biol Blood Marrow Transplant; 2010 Dec; 16(12):1707-17. PubMed ID: 20541028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translation and validation of the Functional Assessment of Cancer Therapy-Bone Marrow Transplant (FACT-BMT) version 4 quality of life instrument into Arabic language.
    Soudy H; Maghfoor I; Elhassan TAM; Abdullah E; Rauf SM; Al Zahrani A; Akhtar S
    Health Qual Life Outcomes; 2018 Mar; 16(1):47. PubMed ID: 29530033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of quality of life in patients with steroid-refractory chronic graft-versus-host disease treated with the mTOR inhibitor everolimus.
    Lutz M; Kapp M; Einsele H; Grigoleit GU; Mielke S
    Clin Transplant; 2014 Dec; 28(12):1410-5. PubMed ID: 25287756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival.
    Moon JH; Sohn SK; Lambie A; Ellis L; Hamad N; Uhm J; Gupta V; Lipton JH; Messner HA; Kuruvilla J; Kim D
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):556-63. PubMed ID: 24447907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient-Reported Outcomes and Mortality in Cutaneous Chronic Graft-vs-Host Disease.
    Baumrin E; Shin DB; Mitra N; Pidala J; El Jurdi N; Lee SJ; Loren AW; Gelfand JM
    JAMA Dermatol; 2024 Apr; 160(4):393-401. PubMed ID: 38416506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms, Cytokines, and Quality of Life in Patients Diagnosed with Chronic Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.
    Lynch Kelly D; Lyon DE; Ameringer SA; Elswick RK
    Oncol Nurs Forum; 2015 May; 42(3):265-75. PubMed ID: 25901378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium.
    Pidala J; Kurland B; Chai X; Majhail N; Weisdorf DJ; Pavletic S; Cutler C; Jacobsohn D; Palmer J; Arai S; Jagasia M; Lee SJ
    Blood; 2011 Apr; 117(17):4651-7. PubMed ID: 21355084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability and Validity of the Modified 7-Day Lee Chronic Graft-versus-Host Disease Symptom Scale.
    Teh C; Onstad L; Lee SJ
    Biol Blood Marrow Transplant; 2020 Mar; 26(3):562-567. PubMed ID: 31759158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne-specific quality of life questionnaire (Acne-QoL): translation, cultural adaptation and validation into Brazilian-Portuguese language.
    Kamamoto Cde S; Hassun KM; Bagatin E; Tomimori J
    An Bras Dermatol; 2014; 89(1):83-90. PubMed ID: 24626652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation, reliability and construct validity of the Tampa scale for kinesiophobia for temporomandibular disorders (TSK/TMD-Br) into Brazilian Portuguese.
    Aguiar AS; Bataglion C; Visscher CM; Bevilaqua Grossi D; Chaves TC
    J Oral Rehabil; 2017 Jul; 44(7):500-510. PubMed ID: 28407268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personality influences quality-of-life assessments in adult patients after allogeneic hematopoietic SCT: results from a joint evaluation of the prospective German Multicenter Validation Trial and the Fred Hutchinson Cancer Research Center.
    Herzberg PY; Lee SJ; Heussner P; Mumm FH; Hilgendorf I; von Harsdorf S; Hemmati P; Rieger K; Greinix HT; Freund M; Holler E; Wolff D
    Bone Marrow Transplant; 2013 Jan; 48(1):129-34. PubMed ID: 22609882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation and cross-cultural adaptation of the lower extremity functional scale into a Brazilian Portuguese version and validation on patients with knee injuries.
    Metsavaht L; Leporace G; Riberto M; Sposito MM; Del Castillo LN; Oliveira LP; Batista LA
    J Orthop Sports Phys Ther; 2012 Nov; 42(11):932-9. PubMed ID: 23047028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the National Institutes of Health (NIH) scale for oral chronic graft-versus-host disease (cGVHD).
    Elad S; Zeevi I; Or R; Resnick IB; Dray L; Shapira MY
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):62-9. PubMed ID: 19733252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review of Patient-Reported Outcome Measures in Graft-versus-Host Disease.
    Kilgour JM; Wali G; Gibbons E; Scherwath A; Barata Badiella A; Peniket A; Schoemans H; Matin RN;
    Biol Blood Marrow Transplant; 2020 May; 26(5):e113-e127. PubMed ID: 32028026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
    Kurosawa S; Oshima K; Yamaguchi T; Yanagisawa A; Fukuda T; Kanamori H; Mori T; Takahashi S; Kondo T; Kohno A; Miyamura K; Umemoto Y; Teshima T; Taniguchi S; Yamashita T; Inamoto Y; Kanda Y; Okamoto S; Atsuta Y
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1749-1758. PubMed ID: 28669922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the relationship between oral chronic graft-versus-host disease and global measures of quality of life.
    DePalo J; Chai X; Lee SJ; Cutler CS; Treister N
    Oral Oncol; 2015 Oct; 51(10):944-9. PubMed ID: 26277616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
    Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
    Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.